Role of phytotherapy associated with antibiotic prophylaxis in female patients with recurrent urinary tract infections

  • Emanuela Frumenzio | emanuela.frumenzio@virgilio.it Clinica Urologica e Andrologica di Perugia, Università degli Studi di Perugia, Italy.
  • Daniele Maglia Clinica Urologica e Andrologica di Perugia, Università degli Studi di Perugia, Italy.
  • Eleonora Salvini Clinica Urologica e Andrologica di Perugia, Università degli Studi di Perugia, Italy.
  • Silvia Giovannozzi Clinica Urologica e Andrologica di Perugia, Università degli Studi di Perugia, Italy.
  • Manuel Di Biase Clinica Urologica e Andrologica di Perugia, Università degli Studi di Perugia, Italy.
  • Vittorio Bini Clinica Urologica e Andrologica di Perugia, Università degli Studi di Perugia, Italy.
  • Elisabetta Costantini Clinica Urologica e Andrologica di Perugia, Università degli Studi di Perugia, Italy.

Abstract

Objective: Aim of this study is to evaluate the efficacy of a phytotherapic which includes Solidago, Orthosiphon and Birch extract (Cistimev®) in association with antibiotic prophylaxis in female patients affected by recurrent urinary tract infections (UTIr). Materials and methods: Patients affected by UTIr older than 18 years started a 3-months antibiotic prophylaxis (Prulifloxacin 600 mg, 1 cps/week or Phosphomicyn 1 cachet/week) according to antibiogram after urine culture. The patients were divided in 2 groups: Group A: antibiotic prophylaxis plus phytotherapy (1 cps/die for 3 months) and Group B: antibiotic prophylaxis alone. Results: 164 consecutive patients were studied: 107 were included in group A (mean age 59 ± 17.3 years) and 57 (mean age 61 ± 15.7) in group B. During the treatment period the relapse frequencies between the two groups were not significantly different (p = 0.854): 12/107 (11.21%) patients interrupted the treatment for UTIr in group A and 6/57 (10.52%) in group B. In the long term follow-up the relapse UTI risk was significant different in the two groups with a relapse risk 2.5 greater in group B than in group A (p < 0.0001). Conclusion: Our study demonstrated that in female patients affected by recurrent UTI, the association between antibiotic prophylaxis and of a phytotherapic which includes Solidago, Orthosiphon and Birch extract reduced the number of UTI in the 12 months following the end of prophylaxis and obtained a longer relapsing time, greatly improving the quality of life of the patients.

Downloads

Download data is not yet available.

METRICS

PlumX Metrics provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.

Published
2013-12-31
Info
Issue
Section
Original Papers - Urogynecology
Keywords:
Recurrent urinary infection, Phytotherapy, Antibiotc prophylaxis
Statistics
  • Abstract views: 2114

  • PDF: 1268
How to Cite
Frumenzio, E., Maglia, D., Salvini, E., Giovannozzi, S., Di Biase, M., Bini, V., & Costantini, E. (2013). Role of phytotherapy associated with antibiotic prophylaxis in female patients with recurrent urinary tract infections. Archivio Italiano Di Urologia E Andrologia, 85(4), 197-199. https://doi.org/10.4081/aiua.2013.4.197